Pituitary Adenylate Cyclase-Activating Peptide is a Potent Modulator of Human Colonic Motility

References

• Miyata A, Arimura A, Dahl R R, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567–74
   PubMed Web of Science ®Google Scholar
• Miyata A, Jiang L, Dahl R R, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643–8
   PubMed Web of Science ®Google Scholar
• Kimura C, Ohkubo S, Ogi K, et al. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun 1990; 164: 81–9
   Google Scholar
• Lam H C, Takahashi K., Ghatei M A, Kanse S M, Polak J M, Bloom S R. Binding sites of a novel neuropeptide pituitary- PACAP Inhibits Colonic Motility 631 adenylate-cyclase-activating polypeptide in the rat brain and lung. Eur J Biochem 1990; 193: 725–9
   PubMedGoogle Scholar
• Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt W E. Characterization of a G-protein coupled receptor for pituitary adenylate cyclase activating peptide on plasma membranes from rat brain. Eur J Biochem 1991; 202: 951–8
   PubMedGoogle Scholar
• Cauvin A, de Neef P, Robberecht P, Gourlet P, Arimura A, Christophe J. Properties and distribution of specific PACAP receptors in rat brain and medulla. Digestion 1990; 46: 41, Suppl 1
   Google Scholar
• Ohtaki T, Watanabe T, Ishibashi Y, et al. Molecular identification of a receptor for pituitary adenylate cyclase activating polypeptide. Biochem Biophys Res Commun 1990; 171: 838–44
   PubMed Web of Science ®Google Scholar
• Gourlet P, Woussen M C, Vandermeers A, Vandermeers-Piret M C, Robberecht P, Christophe J. Pharmacological characterization of specific PACAP receptors in the rat pancreatic acinar cell line AR 4-2J. Digestion 1990; 46: 105, Suppl 1
   PubMed Web of Science ®Google Scholar
• Cauvin A, Buscail L, Gourlet P, et al. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 1990; 11: 773–7
   PubMed Web of Science ®Google Scholar
• Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy D H, Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in rat brain and testes. Endocrinology 1991; 129: 2787–9
   PubMed Web of Science ®Google Scholar
• Sundler F, Ekblad E, Absood A, Hakanson R, Koves K, Arimura A. Pituitary adenylate activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neu-roscience 1992; 46: 439–54
   Google Scholar
• Katsoulis S, Schmidt W E, Schworer H, Creutzfeldt W. PACAP, a novel brain-gut peptide, induces contraction on the guinea pig ileum in vitro. Gastroenterology 1991; 100: A456
   Google Scholar
• Schmidt W E, Hocker M, Katsoulis S, et al. PACAP-27 and PACAP-38-synthesis and biological activity of two novel regulatory brain-gut peptides. Digestion 1990; 46: 281, Suppl 1
   Google Scholar
• Schwörer H, Clemens A, Katsoulis S, Köhler H, Creutzfeldt W, Schmidt W E. The novel gut-brain peptide PACAP inhibits human colonic motility in vitro. Gastroenterology 1992; 102: A511
   Google Scholar
• Bucknell A, Whitney B. A preliminary investigation of the pharmacology of the human isolated taenia coli preparation. Br J Pharmacol 1964; 23: 164–75
   Web of Science ®Google Scholar
• Gagnon D J, Devroede G, Belisle S. Excitatory effects of adrenaline upon isolated preparations of human colon. Gut 1972; 13: 654–7
   PubMed Web of Science ®Google Scholar
• Couture R, Mizrahi J, Regoli D, Devroede G. Peptides and the human colon: an in vitro pharmacological study. Can J Physiol Pharmacol 1981; 59: 957–64
   PubMed Web of Science ®Google Scholar
• Waelbroeck M, Robberecht P, Coy D H, Camus J, de Neef P, Christophe J. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(l-29)-NH2 as a VIP antagonist. Endocrinology 1985; 116: 2643–9
   PubMed Web of Science ®Google Scholar
• Wallenstein S, Zucker C L, Fleiss J L. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9
   PubMed Web of Science ®Google Scholar
• Ishii K, Chang B, Kerwin J F, Huang Z J, Murad F. NG-nitro-L-arginine: a potent inhibitor of EDRF formation. Eur J Pharmacol 1990; 176: 219–24
   PubMed Web of Science ®Google Scholar
• Murray K J. Cyclic AMP and mechanisms of vasodilatation. Pharmacol Ther 1990; 47: 329–45
   PubMed Web of Science ®Google Scholar
• Catterall W A. Neurotoxins that act on voltage sensitive sodium channels in excitable membranes. Ann Rev Pharmacol Toxicol 1980; 20: 15–43
   PubMed Web of Science ®Google Scholar
• Shivers B, Gores T J, Gottschall P E, Arimura A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 1991; 128: 3055–65
   PubMed Web of Science ®Google Scholar
• Burleigh D E. Motor responsiveness of proximal and distal colonic muscle layers to acetylcholine, noradrenaline, and vasoactive intestinal peptide. Dig Dis Sci 1990; 35: 617–21
   PubMed Web of Science ®Google Scholar
• Costa M, Furness J B, Humphreys C MS. Apamin distinguishes two types of relaxation mediated by enteric nerves in the guinea-pig gastrointestinal tract. Naunyn Schmiedebergs Arch Pharmacol 1986; 332: 79–88
   PubMed Web of Science ®Google Scholar
• Edwards G, Weston A H. Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther 1990; 48: 237–58
   PubMed Web of Science ®Google Scholar
• Dreyer F. Peptide toxins and potassium channels. Rev Physiol Biochem Pharmacol 1990; 115: 93–136
   PubMed Web of Science ®Google Scholar
• Maas A JJ, den Hertog A. The effect of apamin on the smooth muscle cells of guinea-pig taenia coli. Eur J Pharmacol 1979; 58: 151–6
   PubMed Web of Science ®Google Scholar
• Maas A JJ, den Hertog A, Ra R, van den Akker J. The action of apamin on guinea-pig taenia caeci. Eur J Pharmacol 1980; 67: 265–74
   PubMed Web of Science ®Google Scholar
• Ito S, Kurokawa A, Ohga A, Ohta T, Sawabe K. Mechanical, electrical and cyclic nucleotide responses to peptide VIP and inhibitory nerve stimulation in rat stomach. J Physiol (Lond) 1990; 430: 337–53
   Google Scholar
• Mackenzie I, Burnstock G. Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli. Eur J Pharmacol 1980; 67: 255–64
   PubMed Web of Science ®Google Scholar
• Taylor G S, Bywater R AR. Novel autonomic neurotransmitters and intestinal function. Pharmacol Ther 1989; 40: 401–38
   PubMed Web of Science ®Google Scholar
• Rattan S, Moummi C. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter. J Pharmacol Exp Ther 1989; 248: 703–9
   PubMed Web of Science ®Google Scholar
• Szewczak S M, Behar J, Bilett G, Hillemeier C, Rhim B Y, Biancani P. VIP-induced alterations in cAMP and inositol phosphates in the lower esophageal sphincter. Am J Physiol 1990; 259: G239–44
   Google Scholar
• Barbier A J, Lefebvre R A. Effect of 3-isobutyl-l-methyl-xanthine and zaprinast on non-adrenergic non-cholinergic relaxation in rat gastric fundus. Eur J Pharmacol 1992; 210: 315–23
   PubMed Web of Science ®Google Scholar
• Ho A K, Chik C L, Klein D C. Transmembrane receptor crosstalk: concurrent VIP and α1-adrenergic activation rapidly elevates pinealocyte cGMP>100-fold. Biochem Biophys Res Commun 1987; 146: 1478–84
   PubMed Web of Science ®Google Scholar
• Audigier S, Barberis C, Jard S. Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion. Brain Res 1986; 376: 363–7
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar